William E. Rote - May 11, 2022 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Senior Vice President, R&D
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Stock symbol
TVTX
Transactions as of
May 11, 2022
Transactions value $
-$33,940
Form type
4
Date filed
5/12/2022, 08:49 PM
Previous filing
Feb 2, 2022
Next filing
Jan 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale -$16.4K -750 -1.66% $21.93 44.5K May 11, 2022 Direct F1
transaction TVTX Common Stock Sale -$17.5K -813 -1.83% $21.52 43.7K May 11, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.